| CereVasc Receives Health Canada Investigational Testing Authorization for STRIDE Clinical Trial of the eShunt® System The STRIDE trial is actively enrolling at multiple sites in the United States and Argentina for the treatment of elderly patients with Normal Pressure Hydrocephalus (NPH) BOSTON, June 18, 2025 /PRNewswire/ – CereVasc, Inc., a clinical-stage medical device company developing novel treatments […] The post CereVasc Receives Health Canada Investigational Testing Authorization for STRIDE Clinical Trial of the eShunt® System appeared first on CereVasc |
Neurological Disease Device |
